Noodle Rat Scenario: Biotech Research Surveillance

BioGenesis Labs: Pharmaceutical research company, 320 scientists, developing breakthrough treatments

APT • NoodleRAT

STAKES

Research data + Clinical trial results + Patent applications + Regulatory compliance

HOOK

BioGenesis is finalizing clinical trial data for FDA submission when researchers notice their workstations occasionally showing signs of remote activity despite no suspicious files being found. Advanced fileless malware is operating entirely in memory, providing competitors invisible surveillance of breakthrough pharmaceutical research and clinical trial results.

PRESSURE

FDA submission deadline Tuesday - research theft threatens $200M drug development investment and regulatory approval

FRONT • 150 minutes • Expert

BioGenesis Labs: Pharmaceutical research company, 320 scientists, developing breakthrough treatments

APT • NoodleRAT

NPCs

• Research Director Dr. Patricia Wong: Leading FDA submission with infected research systems showing invisible surveillance
• IT Security Analyst Michael Foster: Investigating memory-resident malware with no file-based detection signatures
• Clinical Data Manager Jennifer Martinez: Reporting unauthorized access to clinical trial results and patient data
• Regulatory Affairs Director Robert Chen: Assessing FDA compliance risks and pharmaceutical research protection requirements

SECRETS

• Research scientists opened convincing pharmaceutical industry emails containing fileless malware payloads
• Competitors have invisible memory-resident surveillance of clinical trial data and research processes
• Breakthrough pharmaceutical formulations and clinical trial results have been systematically stolen through fileless techniques